Company profile

Amneal Pharmaceuticals, Inc.

NASDAQ:AMRXBiotechnology: Pharmaceutical Preparations

Drug pipeline (316)

AssetStageRevenueTrialsStatus
ABIRATERONE ACETATEapproved26approved
Acebutolol hydrochlorideapproved0
Acetaminophenapproved78approved
Acyclovirapproved0
Albuterol Sulfateapproved3approved

Revenue is the latest reported period from SEC filings. A combination product's amount appears on each of its constituent assets, so those rows are not additive.

Clinical trials (15)

NCT IDPhaseStatusStartCompletionSponsor nameTitle
NCT03562949phase3terminated2018-12-062019-08-02Amneal Ireland LimitedA BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol
NCT06267274phase1unknown2024-04-012025-03-01Amneal Pharmaceuticals, LLCA Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
NCT03562923phase3unknown2018-10-012019-05-01Amneal Ireland LimitedA Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50
NCT02940561phase1unknown2016-08-012016-10-01Amneal Pharmaceuticals, LLCBE Study in Patients - Methotrexate Tablets
NCT02072954phase2_3completed2013-11-012014-02-01Amneal Pharmaceuticals, LLCBioequivalence Fasting Study in Patients

FDA applications (451)

ApplicationTypeApplicantProducts
ANDA 040625ANDAAMNEAL PHARMACEUTICAL
ANDA 040729ANDAAMNEAL PHARMACEUTICALS NY LLC
ANDA 040736ANDAAMNEAL PHARMACEUTICALS NY LLC
ANDA 040746ANDAAMNEAL PHARMACEUTICALS NY LLC
ANDA 040748ANDAAMNEAL PHARMACEUTICALS NY LLC